157 related articles for article (PubMed ID: 25355558)
1. Genetic variations in IDH gene as prognosis predictors in TACE-treated hepatocellular carcinoma patients.
Zhang H; Guo X; Dai J; Wu Y; Ge N; Yang Y; Ji J; Zhang H
Med Oncol; 2014 Nov; 31(11):278. PubMed ID: 25355558
[TBL] [Abstract][Full Text] [Related]
2. Functional polymorphisms in the NPAS2 gene are associated with overall survival in transcatheter arterial chemoembolization-treated hepatocellular carcinoma patients.
Yuan P; Wang S; Zhou F; Wan S; Yang Y; Huang X; Zhang Z; Zhu Y; Zhang H; Xing J
Cancer Sci; 2014 Jul; 105(7):825-32. PubMed ID: 24754267
[TBL] [Abstract][Full Text] [Related]
3. Functional polymorphisms of circadian negative feedback regulation genes are associated with clinical outcome in hepatocellular carcinoma patients receiving radical resection.
Zhang Z; Ma F; Zhou F; Chen Y; Wang X; Zhang H; Zhu Y; Bi J; Zhang Y
Med Oncol; 2014 Dec; 31(12):179. PubMed ID: 25344870
[TBL] [Abstract][Full Text] [Related]
4. Genetic variants in genes of tricarboxylic acid cycle key enzymes predict postsurgical overall survival of patients with hepatocellular carcinoma.
Du X; Wan S; Chen Y; Qu P; Huang X; Yu X; Yang H; Zhang Y; Xing J
Ann Surg Oncol; 2014 Dec; 21(13):4300-7. PubMed ID: 25081338
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms of glutathione S-transferase genes and survival of resected hepatocellular carcinoma patients.
Qu K; Liu SS; Wang ZX; Huang ZC; Liu SN; Chang HL; Xu XS; Lin T; Dong YF; Liu C
World J Gastroenterol; 2015 Apr; 21(14):4310-22. PubMed ID: 25892883
[TBL] [Abstract][Full Text] [Related]
6. Genetic Variants in ASCT2 Gene are Associated with the Prognosis of Transarterial Chemoembolisation-Treated Early- Stage Hepatocelluar Carcinoma.
Ge NJ; Shi ZY; Yu XH; Huang XJ; Wu YS; Chen YY; Zhang J; Yang YF
Asian Pac J Cancer Prev; 2015; 16(9):4103-7. PubMed ID: 25987094
[TBL] [Abstract][Full Text] [Related]
7. Thymidylate synthase gene polymorphisms as important contributors affecting hepatocellular carcinoma prognosis.
Wang X; Sun X; Du X; Zhou F; Yang F; Xing J; Dong G; Guo X
Clin Res Hepatol Gastroenterol; 2017 Jun; 41(3):319-326. PubMed ID: 28043790
[TBL] [Abstract][Full Text] [Related]
8. A genetic variant (rs17251221) in the calcium-sensing receptor relates to hepatocellular carcinoma susceptibility and clinical outcome treated by transcatheter hepatic arterial chemoembolization (TACE) therapy.
Tang Q; Zhao Y; Wang Y; Wei M
Med Oncol; 2014 Nov; 31(11):267. PubMed ID: 25270285
[TBL] [Abstract][Full Text] [Related]
9. Genetic variants in genes of tricarboxylic acid cycle key enzymes are associated with prognosis of patients with non-small cell lung cancer.
Guo X; Li D; Wu Y; Chen Y; Zhou X; Wang X; Huang X; Li X; Yang H; Xing J
Lung Cancer; 2015 Feb; 87(2):162-8. PubMed ID: 25576295
[TBL] [Abstract][Full Text] [Related]
10. Genetic variants in the EPCAM gene is associated with the prognosis of transarterial chemoembolization treated hepatocellular carcinoma with portal vein tumor thrombus.
Yu X; Ge N; Guo X; Shen S; Liang J; Huang X; Wan S; Xing J; Huang Q; Yang Y
PLoS One; 2014; 9(4):e93416. PubMed ID: 24718422
[TBL] [Abstract][Full Text] [Related]
11. A functional polymorphism in PER3 gene is associated with prognosis in hepatocellular carcinoma.
Zhao B; Lu J; Yin J; Liu H; Guo X; Yang Y; Ge N; Zhu Y; Zhang H; Xing J
Liver Int; 2012 Oct; 32(9):1451-9. PubMed ID: 22809120
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in genes of the de novo lipogenesis pathway and overall survival of hepatocellular carcinoma patients undergoing transarterial chemoembolization.
Wu YS; Bao DK; Dai JY; Chen C; Zhang HX; Yang Y; Xing JL; Huang XJ; Wan SG
Asian Pac J Cancer Prev; 2015; 16(3):1051-6. PubMed ID: 25735330
[TBL] [Abstract][Full Text] [Related]
13. N6-methyladenosine reader YTHDC2 and eraser FTO may determine hepatocellular carcinoma prognoses after transarterial chemoembolization.
Liu J; Wang D; Zhou J; Wang L; Zhang N; Zhou L; Zeng J; Liu J; Yang M
Arch Toxicol; 2021 May; 95(5):1621-1629. PubMed ID: 33713148
[TBL] [Abstract][Full Text] [Related]
14. Genetic variants in the KDR gene is associated with the prognosis of transarterial chemoembolization treated hepatocellular carcinoma.
Zheng YB; Huang JW; Zhan MX; Zhao W; Liu B; He X; Li Y; Hu BS; Lu LG
Tumour Biol; 2014 Nov; 35(11):11473-81. PubMed ID: 25123269
[TBL] [Abstract][Full Text] [Related]
15. Roles of XRCC1/XPD/ERCC1 Polymorphisms in Predicting Prognosis of Hepatocellular Carcinoma in Patients Receiving Transcatheter Arterial Chemoembolization.
Wang XC; Wang F; Quan QQ
Genet Test Mol Biomarkers; 2016 Apr; 20(4):176-84. PubMed ID: 26918371
[TBL] [Abstract][Full Text] [Related]
16. Genetic variants in de novo lipogenic pathway genes predict the prognosis of surgically-treated hepatocellular carcinoma.
Jiang H; Dai J; Huang X; Chen Y; Qu P; Li J; Yi C; Yang Y; Zhang K; Huang Q
Sci Rep; 2015 Mar; 5():9536. PubMed ID: 25826294
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in Genes of Tricarboxylic Acid Cycle Key Enzymes Are Associated with Early Recurrence of Hepatocellular Carcinoma.
Wan S; Wu Y; Zhou X; Chen Y; An J; Yu X; Zhang H; Yang H; Xing J
PLoS One; 2015; 10(4):e0124471. PubMed ID: 25894340
[TBL] [Abstract][Full Text] [Related]
18. Predictive performance of the mHAP-II score in a real-life western cohort with hepatocellular carcinoma following trans-arterial chemoembolisation with drug-eluting beads (DEB-TACE).
Peisen F; Maurer M; Grosse U; Nikolaou K; Syha R; Ketelsen D; Artzner C; Bitzer M; Horger M; Grözinger G
Eur Radiol; 2020 Jul; 30(7):3782-3792. PubMed ID: 32125515
[TBL] [Abstract][Full Text] [Related]
19. LncRNA H19 modulated by miR-146b-3p/miR-1539-mediated allelic regulation in transarterial chemoembolization of hepatocellular carcinoma.
Song Y; Xing H; Zhou L; Zhang N; Yang M
Arch Toxicol; 2021 Sep; 95(9):3063-3070. PubMed ID: 34251499
[TBL] [Abstract][Full Text] [Related]
20. Alterations of telomere length and mtDNA copy number are associated with overall survival in hepatocellular carcinoma patients treated with transarterial chemoembolization.
Bao D; Ba Y; Zhou F; Zhao J; Yang Q; Ge N; Guo X; Wu Z; Zhang H; Yang H; Wan S; Xing J
Cancer Chemother Pharmacol; 2016 Oct; 78(4):791-9. PubMed ID: 27558242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
